Annals of Clinical Microbiology and Antimicrobials

Scope & Guideline

Pioneering discussions that shape the future of healthcare.

Introduction

Welcome to your portal for understanding Annals of Clinical Microbiology and Antimicrobials, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationANN CLIN MICROB ANTI / Ann. Clin. Microbiol. Antimicrob.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Annals of Clinical Microbiology and Antimicrobials focuses on advancing the understanding of microbial infections and the development of antimicrobial strategies. It encompasses a wide range of clinical microbiology topics, emphasizing the importance of antimicrobial resistance and innovative diagnostic methods.
  1. Clinical Microbiology Research:
    The journal publishes research on the diagnosis, treatment, and prevention of infectious diseases, highlighting clinical case studies and epidemiological data.
  2. Antimicrobial Resistance Studies:
    A significant focus is placed on understanding the mechanisms and prevalence of antimicrobial resistance, including studies on resistant strains and their clinical implications.
  3. Innovative Diagnostic Techniques:
    Research on novel diagnostic methodologies, particularly the application of next-generation sequencing and other omics technologies, is a prominent theme, aimed at enhancing pathogen detection and characterization.
  4. Infection Control and Management:
    The journal emphasizes strategies for effective infection management and control, including the evaluation of treatment regimens and the impact of antimicrobial stewardship programs.
  5. Global Health Perspectives:
    The scope includes global epidemiological studies that address public health concerns related to infectious diseases, particularly in low and middle-income countries.
Recent publications indicate several emerging trends and themes within the Annals of Clinical Microbiology and Antimicrobials, reflecting the evolving landscape of clinical microbiology research.
  1. Metagenomic and Genomic Approaches:
    There is a marked increase in studies utilizing metagenomic and whole-genome sequencing techniques to identify pathogens and understand microbial communities, showcasing the shift towards precision microbiology.
  2. Antimicrobial Stewardship and Resistance Management:
    Research focusing on antimicrobial stewardship practices and the management of resistant infections is trending, reflecting a global concern over rising resistance rates.
  3. Integrative and Novel Therapeutic Strategies:
    Emerging studies are exploring innovative therapeutic combinations and novel agents, including phage therapy and antimicrobial peptides, as potential solutions to combat multidrug-resistant infections.
  4. Infection Epidemiology in Vulnerable Populations:
    There is growing emphasis on the epidemiology of infections in vulnerable groups, such as immunocompromised patients and those in resource-limited settings, highlighting the need for targeted interventions.
  5. Impact of COVID-19 on Microbial Infections:
    The COVID-19 pandemic has spurred interest in secondary bacterial infections and the interplay between viral and bacterial pathogens, leading to a surge in related research.

Declining or Waning

While the journal has continued to publish a diverse range of topics, certain areas have seen a decrease in focus over recent years. These themes may reflect shifting research priorities in the field of clinical microbiology.
  1. Traditional Culture-Based Diagnostics:
    There appears to be a waning interest in traditional culture-based diagnostic methods, as researchers increasingly favor molecular and rapid diagnostic techniques.
  2. General Antibiotic Efficacy Studies:
    Studies solely focused on the efficacy of antibiotics without exploring resistance mechanisms or combined therapies have become less prominent, indicating a shift towards more complex investigations.
  3. Non-Pathogen Specific Research:
    Research that does not focus on specific pathogens or clinical outcomes is declining, as the journal increasingly prioritizes studies with direct clinical relevance and implications.

Similar Journals

Indian Journal of Medical Microbiology

Your Gateway to Open Access Microbiological Research
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Surgical Infections

Elevating standards in the study of surgical infections.
Publisher: MARY ANN LIEBERT, INCISSN: 1096-2964Frequency: 10 issues/year

Surgical Infections, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to advancing the understanding and management of infections associated with surgical procedures. With an ISSN of 1096-2964 and an E-ISSN of 1557-8674, this journal has emerged as a vital resource within the fields of Infectious Diseases, Surgery, and Microbiology. Over the years, it has established a notable presence, achieving a 2023 Q2 ranking in Infectious Diseases and Surgery, as well as a Q3 ranking in Microbiology. The journal holds an impressive position at 74th percentile in Surgery according to Scopus, making it a reliable platform for disseminating current research and clinical practices. Surgical Infections aims to provide an interdisciplinary forum for both seasoned professionals and academics, encouraging the exploration of novel therapeutic approaches, prevention strategies, and case studies that address the complexities of surgical-related infections. As the field continues to evolve, this journal remains committed to fostering innovative research that enhances clinical outcomes and patient safety.

JOURNAL OF INFECTION

Exploring Innovations in Microbial Research
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

Infectious Diseases and Clinical Microbiology

Uniting scholars to combat infectious diseases worldwide.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Lancet Microbe

Advancing the Frontiers of Microbial Research
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Fostering innovation in the understanding of infectious agents.
Publisher: EDICIONES DOYMA S AISSN: 0213-005XFrequency: 10 issues/year

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

Southern African Journal of Infectious Diseases

Connecting knowledge to combat infectious diseases.
Publisher: AOSISISSN: 2312-0053Frequency: 4 issues/year

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

Journal of Pathogens

Transforming Insights into Actionable Knowledge
Publisher: HINDAWI LTDISSN: 2090-3057Frequency:

Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

Frontiers in Cellular and Infection Microbiology

Leading the charge in microbiological excellence.
Publisher: FRONTIERS MEDIA SAISSN: 2235-2988Frequency: 1 issue/year

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

Antimicrobial Resistance and Infection Control

Elevating awareness and research on resistance challenges.
Publisher: BMCISSN: 2047-2994Frequency: 1 issue/year

Antimicrobial Resistance and Infection Control is a leading open access journal published by BMC, dedicated to the dissemination of research in the critical area of antimicrobial resistance and its impact on infection control practices. Since its inception in 2012, the journal has quickly established itself as a vital resource for researchers, healthcare professionals, and policymakers, featuring a robust array of studies that address the escalating threats posed by antimicrobial resistance across various contexts. With its impressive Q1 rankings across multiple categories—including Infectious Diseases, Microbiology, Pharmacology, and Public Health—the journal’s influence is underscored by its consistent placement in the upper echelons of academic research. Furthermore, it holds commendable ranks in Scopus, with percentiles placing it in the top tier of its respective fields. The journal serves as an essential platform for innovative research and discussions aimed at curbing the threats of antimicrobial resistance, thereby supporting the global health community in striving for effective solutions to safeguard public health.